Deep Track Capital, LP 13D and 13G filings for Oruka Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-13 4:32 pm Purchase |
2025-05-06 | 13G | Oruka Therapeutics, Inc. ORKA |
Deep Track Capital, LP | 1,896,780 5.070% |
1,896,780 (New Position) |
Filing |